First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland

Simpson, C R, Shi, T, Vasileiou, E, Katikireddi, S V, Kerr, S, Moore, E, McCowan, C, Agrawal, U, Shah, S A, Ritchie, L D, Murray, J, Pan, J, Bradley, D T, Stock, S J, Wood, R, Chuter, A, Beggs, J, Stagg, H R, Joy, M, Tsang, R S M, de Lusignan, S, Hobbs, R, Lyons, R A, Torabi, F, Bedston, S, O'Leary, M, Akbari, A, McMenamin, J, Robertson, C & Sheikh, A 2021, 'First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland', Nature Medicine, vol. 27, pp. 1290-1297. https://doi.org/10.1038/s41591-021-01408-4